268 related articles for article (PubMed ID: 32745630)
1. Accuracy of non-invasive methods/models for predicting esophageal varices in patients with compensated advanced chronic liver disease secondary to nonalcoholic fatty liver disease.
Galizzi HO; Couto CA; Taranto DOL; Araújo SIO; Vilela EG
Ann Hepatol; 2021; 20():100229. PubMed ID: 32745630
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
[TBL] [Abstract][Full Text] [Related]
3. Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort.
Sharma S; Agarwal S; Gunjan D; Kaushal K; Anand A; Saraya A
Am J Gastroenterol; 2020 Oct; 115(10):1650-1656. PubMed ID: 32516202
[TBL] [Abstract][Full Text] [Related]
4. Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease.
Lee HA; Kim SU; Seo YS; Lee YS; Kang SH; Jung YK; Kim MY; Kim JH; Kim SG; Suk KT; Jung SW; Jang JY; An H; Yim HJ; Um SH
Liver Int; 2019 Jun; 39(6):1071-1079. PubMed ID: 30589490
[TBL] [Abstract][Full Text] [Related]
5. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
[TBL] [Abstract][Full Text] [Related]
6. Non-Invasive Prediction of High-Risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
Moctezuma-Velazquez C; Saffioti F; Tasayco-Huaman S; Casu S; Mason A; Roccarina D; Vargas V; Nilsson JE; Tsochatzis E; Augustin S; Montano-Loza AJ; Berzigotti A; Thorburn D; Genesca J; Abraldes JG
Am J Gastroenterol; 2019 Mar; 114(3):446-452. PubMed ID: 30315285
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of three "beyond Baveno VI" criteria to safely spare endoscopies in compensated advanced chronic liver disease.
Tosetti G; Primignani M; La Mura V; D'Ambrosio R; Degasperi E; Mezzina N; Viganò M; Rumi M; Fracanzani AL; Lombardi R; Fargion S; Fraquelli M; Aghemo A; Lampertico P
Dig Liver Dis; 2019 Aug; 51(8):1135-1140. PubMed ID: 30691777
[TBL] [Abstract][Full Text] [Related]
8. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.
Nawalerspanya S; Sripongpun P; Chamroonkul N; Kongkamol C; Piratvisuth T
Ann Hepatol; 2020; 19(2):209-213. PubMed ID: 31607647
[TBL] [Abstract][Full Text] [Related]
9. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.
Pizzamiglio M; Weicker A; de Terwangne C; Henrion J; Descamps OS; De Vos M
Acta Gastroenterol Belg; 2022; 85(2):321-329. PubMed ID: 35709776
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease.
Merchante N; Saroli Palumbo C; Mazzola G; Pineda JA; Téllez F; Rivero-Juárez A; Ríos-Villegas MJ; Maurice JB; Westbrook RH; Judge R; Guaraldi G; Schepis F; Perazzo H; Rockstroh J; Boesecke C; Klein MB; Cervo A; Ghali P; Wong P; Petta S; De Ledinghen V; Macías J; Sebastiani G
Clin Infect Dis; 2020 Dec; 71(11):2810-2817. PubMed ID: 31813962
[TBL] [Abstract][Full Text] [Related]
11. Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort.
Gaete MI; Díaz LA; Arenas A; González K; Cattaneo M; Fuster F; Henríquez R; Soza A; Arrese M; Barrera F; Arab JP; Benítez C
Liver Int; 2020 Jun; 40(6):1427-1434. PubMed ID: 31916360
[TBL] [Abstract][Full Text] [Related]
12. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.
Zhou H; Long J; Hu H; Tian CY; Lin SD
World J Gastroenterol; 2019 Sep; 25(35):5323-5333. PubMed ID: 31558876
[TBL] [Abstract][Full Text] [Related]
13. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease.
Augustin S; Pons M; Maurice JB; Bureau C; Stefanescu H; Ney M; Blasco H; Procopet B; Tsochatzis E; Westbrook RH; Bosch J; Berzigotti A; Abraldes JG; Genescà J
Hepatology; 2017 Dec; 66(6):1980-1988. PubMed ID: 28696510
[TBL] [Abstract][Full Text] [Related]
14. Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices.
Dong TS; Kalani A; Aby ES; Le L; Luu K; Hauer M; Kamath R; Lindor KD; Tabibian JH
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1894-1901.e1. PubMed ID: 30708109
[TBL] [Abstract][Full Text] [Related]
15. Comparison of screening strategies with two new tests to score and diagnose varices needing treatment.
Calès P; Ravaioli F; Berger A; Farcau O; Festi D; Stefanescu H; Vitellius C; Nahon P; Bureau C; Ganne-Carriè N; Berzigotti A; de Ledinghen V; Petta S
Clin Res Hepatol Gastroenterol; 2022; 46(7):101925. PubMed ID: 35470108
[TBL] [Abstract][Full Text] [Related]
16. Elastography-based screening for esophageal varices in patients with advanced chronic liver disease.
Paternostro R; Reiberger T; Bucsics T
World J Gastroenterol; 2019 Jan; 25(3):308-329. PubMed ID: 30686900
[TBL] [Abstract][Full Text] [Related]
17. Spleen Stiffness-Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver Disease.
Vanderschueren E; Armandi A; Kwanten W; Cassiman D; Francque S; Schattenberg JM; Laleman W
Am J Gastroenterol; 2024 Mar; ():. PubMed ID: 38502095
[TBL] [Abstract][Full Text] [Related]
18. [Noninvasive assessment of the risk of esophageal variceal bleeding from noncirrhotic portal hypertension].
Xu HF; Wang Y; He FL; Fan ZH; Liu H; Yang YP; Jia JD; Liu FQ; Ding HG
Zhonghua Gan Zang Bing Za Zhi; 2022 Oct; 30(10):1092-1099. PubMed ID: 36727234
[No Abstract] [Full Text] [Related]
19. Usefulness of noninvasive methods including assessment of liver stiffness by 2-dimensional shear wave elastography for predicting esophageal varices.
Yoo HW; Kim YS; Kim SG; Yoo JJ; Jeong SW; Jang JY; Lee SH; Kim HS; Kim YD; Cheon GJ; Jun B; Kim BS
Dig Liver Dis; 2019 Dec; 51(12):1706-1712. PubMed ID: 31281068
[TBL] [Abstract][Full Text] [Related]
20. Baveno criteria perform better than expanded Baveno and Rete Sicilia Selezione Terapia-Hepatitis C virus criteria for predicting varices needing treatment.
Agarwal A; Pathak P; Gupta S; Kumar R; Shalimar
Indian J Gastroenterol; 2021 Dec; 40(6):590-597. PubMed ID: 33991311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
